- Home
- ALE vs APLS Comparison
ALE vs APLS Comparison
Compare ALE & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALE
- APLS
- Stock Information
- Founded
- ALE 1906
- APLS 2009
- Country
- ALE United States
- APLS United States
- Employees
- ALE N/A
- APLS N/A
- Industry
- ALE Power Generation
- APLS Biotechnology: Pharmaceutical Preparations
- Sector
- ALE Utilities
- APLS Health Care
- Exchange
- ALE Nasdaq
- APLS Nasdaq
- Market Cap
- ALE 3.7B
- APLS 4.4B
- IPO Year
- ALE N/A
- APLS 2017
- Fundamental
- Price
- ALE $64.34
- APLS $27.75
- Analyst Decision
- ALE Hold
- APLS Buy
- Analyst Count
- ALE 4
- APLS 19
- Target Price
- ALE $62.00
- APLS $49.89
- AVG Volume (30 Days)
- ALE 243.3K
- APLS 4.0M
- Earning Date
- ALE 10-30-2024
- APLS 11-05-2024
- Dividend Yield
- ALE 4.38%
- APLS N/A
- EPS Growth
- ALE N/A
- APLS N/A
- EPS
- ALE 3.12
- APLS N/A
- Revenue
- ALE $1,567,700,000.00
- APLS $715,216,000.00
- Revenue This Year
- ALE N/A
- APLS $95.59
- Revenue Next Year
- ALE $11.39
- APLS $13.77
- P/E Ratio
- ALE $20.65
- APLS N/A
- Revenue Growth
- ALE N/A
- APLS 162.10
- 52 Week Low
- ALE $54.71
- APLS $24.34
- 52 Week High
- ALE $65.86
- APLS $73.80
- Technical
- Relative Strength Index (RSI)
- ALE 47.69
- APLS 47.09
- Support Level
- ALE $63.97
- APLS $25.76
- Resistance Level
- ALE $64.60
- APLS $30.80
- Average True Range (ATR)
- ALE 0.46
- APLS 1.84
- MACD
- ALE -0.05
- APLS 0.04
- Stochastic Oscillator
- ALE 28.88
- APLS 52.79
About ALE Allete Inc.
ALLETE Inc provides competitively-priced energy in America's Upper Midwest region and invests in transmission infrastructure and other energy-centric businesses. The company has two reportable segments. The first segment is Regulated Operations, which includes the company's regulated utilities, Minnesota Power and SWL&P, as well as its investment in ATC. ATC is a regulated utility based in Wisconsin that owns and maintains electric transmission assets in parts of Wisconsin, Michigan, Minnesota, and Illinois. The second segment is ALLETE Clean Energy, which focuses on developing, acquiring, and operating clean and renewable energy projects.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.